Karin Blakolmer

1.4k total citations
20 papers, 628 citations indexed

About

Karin Blakolmer is a scholar working on Surgery, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Karin Blakolmer has authored 20 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Hepatology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Karin Blakolmer's work include Organ Transplantation Techniques and Outcomes (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Psychedelics and Drug Studies (5 papers). Karin Blakolmer is often cited by papers focused on Organ Transplantation Techniques and Outcomes (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Psychedelics and Drug Studies (5 papers). Karin Blakolmer collaborates with scholars based in United States, South Africa and Israel. Karin Blakolmer's co-authors include Catherine M. Verfaillie, Philip B. McGlave, Simon C. Robson, Christine Mannhalter, Anthony J. Demetris, Andreas Chott, J. Alain Kummer, W. Jurecka, Harold A. Dunsford and Michael Vesely and has published in prestigious journals such as The Journal of Experimental Medicine, Hepatology and Journal of Hepatology.

In The Last Decade

Karin Blakolmer

19 papers receiving 611 citations

Peers

Karin Blakolmer
Christine Appelt Germany
L Bonsi Italy
Masayasu Kitano Japan
Pasquale Barbaro Australia
Cécile Masson France
Satoshi Saida Japan
PD Kottaridis United Kingdom
Beryl Crossley United States
L. Schwartzberg United States
Christine Appelt Germany
Karin Blakolmer
Citations per year, relative to Karin Blakolmer Karin Blakolmer (= 1×) peers Christine Appelt

Countries citing papers authored by Karin Blakolmer

Since Specialization
Citations

This map shows the geographic impact of Karin Blakolmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Blakolmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Blakolmer more than expected).

Fields of papers citing papers by Karin Blakolmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Blakolmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Blakolmer. The network helps show where Karin Blakolmer may publish in the future.

Co-authorship network of co-authors of Karin Blakolmer

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Blakolmer. A scholar is included among the top collaborators of Karin Blakolmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Blakolmer. Karin Blakolmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lerer, Elad, Alex Buko, Karin Blakolmer, et al.. (2024). Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Molecular Psychiatry. 29(7). 2059–2073. 15 indexed citations
2.
3.
4.
Lerer, Leonard, et al.. (2023). Incilius alvarius Cell-Based Synthesis of 5-Methoxy-N,N-Dimethyltryptamine. PubMed. 1(1). 38–42. 1 indexed citations
5.
Wolf, Gilly, Sandeep Singh, Karin Blakolmer, et al.. (2022). Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Molecular Psychiatry. 28(1). 44–58. 24 indexed citations
6.
Brown, Carolyn M., et al.. (2022). COVID-19 vaccination and race – A nationwide survey of vaccination status, intentions, and trust in the US general population. Journal of Managed Care & Specialty Pharmacy. 28(12). 1429–1438. 11 indexed citations
7.
Sebagh, Mylène, Karin Blakolmer, Bruno Falissard, et al.. (2002). Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema. Hepatology. 35(1). 117–125. 18 indexed citations
8.
Randhawa, Parmjeet, Karin Blakolmer, Randeep Kashyap, et al.. (2001). Allograft Liver Biopsy in Patients With Epstein-Barr Virus–Associated Posttransplant Lymphoproliferative Disease. The American Journal of Surgical Pathology. 25(3). 324–330. 8 indexed citations
9.
Blakolmer, Karin, Michael Vesely, J. Alain Kummer, et al.. (2000). Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell Lymphomas. Modern Pathology. 13(7). 766–772. 64 indexed citations
10.
Blakolmer, Karin, Philippe Gaulard, Christine Mannhalter, et al.. (2000). UNUSUAL PERIPHERAL T CELL LYMPHOMA PRESENTING AS ACUTE LIVER FAILURE AND REAPPEARING IN THE LIVER ALLOGRAFT. Transplantation. 70(12). 1802–1805. 17 indexed citations
11.
Blakolmer, Karin, A Jain, Kristine Ruppert, et al.. (2000). CHRONIC LIVER ALLOGRAFT REJECTION IN A POPULATION TREATED PRIMARILY WITH TACROLIMUS AS BASELINE IMMUNOSUPPRESSION. Transplantation. 69(11). 2330–2336. 53 indexed citations
12.
Blakolmer, Karin, et al.. (2000). CHRONIC LIVER ALLOGRAFT REJECTION IN A POPULATION TREATED PRIMARILY WITH TACROLIMUS AS BASELINE IMMUNOSUPPRESSION. 9 indexed citations
13.
Blakolmer, Karin, Eric C. Seaberg, Kenneth P. Batts, et al.. (1999). Analysis of the Reversibility of Chronic Liver Allograft Rejection Implications for a Staging Schema*. The American Journal of Surgical Pathology. 23(11). 1328–1328. 39 indexed citations
14.
Lemmer, Eric R., Enid Shephard, Karin Blakolmer, Ralph E. Kirsch, & Simon C. Robson. (1998). Isolation from human fetal liver of cells co-expressing CD34 haematopoietic stem cell and CAM 5.2 pancytokeratin markers. Journal of Hepatology. 29(3). 450–454. 42 indexed citations
15.
Essop, M. Faadiel, et al.. (1997). Analysis of low and high grade B‐cell lymphoma subtypes using semi‐nested PCR and two primer sets. European Journal Of Haematology. 59(3). 136–141. 15 indexed citations
16.
Blakolmer, Karin, M. Faadiel Essop, & Pauline Close. (1996). Diagnosis of an Anemone Cell Tumor as a B-Cell Lymphoma by Molecular Analysis. Ultrastructural Pathology. 20(2). 189–193. 1 indexed citations
17.
Jaśkiewicz, K, et al.. (1996). Increased Matrix Proteins, Collagen and Transforming Growth Factor are Early Markers of Hepatotoxicity in Patients on Long-Term Methotrexate Therapy. Journal of Toxicology Clinical Toxicology. 34(3). 301–305. 12 indexed citations
18.
Blakolmer, Karin, et al.. (1995). Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver. Hepatology. 21(6). 1510–1516. 44 indexed citations
19.
Blakolmer, Karin. (1995). Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver. Hepatology. 21(6). 1510–1516. 1 indexed citations
20.
Verfaillie, Catherine M., Karin Blakolmer, & Philip B. McGlave. (1990). Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.. The Journal of Experimental Medicine. 172(2). 509–502. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Appelt Breakdown of academic impact, for papers by L Bonsi Breakdown of academic impact, for papers by Masayasu Kitano Breakdown of academic impact, for papers by Pasquale Barbaro Breakdown of academic impact, for papers by Cécile Masson Breakdown of academic impact, for papers by Satoshi Saida Breakdown of academic impact, for papers by PD Kottaridis Breakdown of academic impact, for papers by Beryl Crossley Breakdown of academic impact, for papers by L. Schwartzberg
Rankless by CCL
2026